News

Providing a diverse range of perspectives from bullish to bearish, 18 analysts have published ratings on Duolingo (NASDAQ:DUOL) in the last three months. Summarizing their recent assessments ...
PITTSBURGH, April 30, 2025 (GLOBE NEWSWIRE) -- Duolingo (NASDAQ: DUOL), the world’s leading mobile learning platform, today announced the launch of 148 new language courses, more than doubling ...
Duolingo (NASDAQ: DUOL) faces threats to its business from the rising effectiveness of artificial intelligence. *Stock prices used were the afternoon prices of April 24, 2025. The video was ...
Duolingo has announced an unprecedented expansion with the launch of 148 new language courses, more than doubling its existing offerings. This expansion allows the company's seven most popular non ...
Duolingo, Inc. (DUOL) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.52 per share. This compares to earnings of $0.57 per share a year ago.
DUOLINGO ($DUOL) posted quarterly earnings results on Thursday, May 1st. The company reported earnings of $0.72 per share, beating estimates of $0.53 by $0.19. The ...
For the quarter ended March 2025, Duolingo, Inc. (DUOL) reported revenue of $230.74 million, up 37.7% over the same period last year. EPS came in at $0.72, compared to $0.57 in the year-ago quarter.
Duolingo, a leading language platform, grows with global expansion and AI tiers. Revenues up 41% in 2024, but valuation may ...
We recently published a list of the 30 Stocks That Should Double in 3 Years. In this article, we are going to take a look at ...
Duolingo (NASDAQ: DUOL) faces threats to its business from the rising effectiveness of artificial intelligence. *Stock prices ...
Language-learning app Duolingo (NASDAQ:DUOL) announced in Q1 CY2025, with sales up 37.7% year on year to $230.7 million.
In this article, we are going to take a look at where Duolingo, Inc. (NASDAQ:DUOL) stands against other stocks that should double in 3 years. On April 25, Kari Firestone, Aureus Asset Management ...